Clinical Trials

Cancer Type: GI Cancers

Hospitals offering this trial


IRB Pro-248
FOLFOX PGx: A Pilot Prospective Clinical Trial to use Personalized Medicine through Pharmacogenetics in the Treatment of Gastrointestinal Cancers

The purpose of this study is to determine if prospectively testing subjects for variations in genes involved in the pharmacologic disposition of the FOLFOX combination in patients with gastrointestinal malignancies is feasible.

Lombardi/MedStar Georgetown Hospital; MedStar Montgomery Medical Center



Contact: John Marshall, MD
Phone: 202-405-2852